Advanced Search
Submit Manuscript Volume 33, No 7, Jul 2023
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 33 Issue 7, July 2023: 562-564
Bacterial coinfections contribute to severe COVID-19 in winter
Hui Fan1,? , Li Zhou2,? , Jingjun Lv3,? , Shimin Yang4,? , Guozhong Chen1,? , Xinjin Liu4,? , Chunyan Han4,? , Xue Tan4 , Shengnan Qian4 , Zegang Wu5 , Shan Yu1 , Ming Guo4 , Chengliang Zhu5,* , Yu Chen4,* , Ke Lan2,4,*
1State Key Laboratory of Virology, Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei, ChinaDear Editor,
Although most cases of COVID-19 caused by SARS-CoV-2 Omicron variants are mild or asymptomatic worldwide, coinfection with SARS-CoV-2 and other respiratory pathogens may still aggravate the severity of the illness.1,2 The current literature indicates that coinfection with COVID-19 could occur in 3.70%–9.7% of patients.1,3,4 The proportion of bacterial, and other respiratory viral coinfections may range from 3.02% to 9.7% and 5.41% to 6.61%, respectively. However, these studies demonstrated that coinfections with respiratory pathogens are not common. Thus, antibacterial therapy and diagnostic tests are considered to be unnecessary upon admission for most patients hospitalized with COVID-19.3,5
https://doi.org/10.1038/s41422-023-00821-3